SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel slashes employee bonuses amid financial struggles

Way off-brand: Israel ranked dead last in global Nation Brands Index

Innoviz cuts 9% of workforce in latest round of layoffs amid financial struggles

Deel secures $300M secondary transaction at over $12B valuation, hits $800M revenue run rate

Buzz

Most popular

Daily

Weekly

1

Intel slashes employee bonuses amid financial struggles

2

Intel pulls the plug on AI chip designed to rival Nvidia

3

Deel secures $300M secondary transaction at over $12B valuation, hits $800M revenue run rate

4

Unicorn AppsFlyer lays off 100 employees in strategic restructuring

5

Bigabid raises $25 million Series A to boost gaming adtech growth

Sol-Gel

3 stories about Sol-Gel

זיפים גילוח זקן

Perrigo to Collaborate with Acne Cream Company Sol-Gel on Generic Drug

Nasdaq-listed Sol-Gel is a clinical-stage company developing topical products for skin conditions

Acne Cream Developer Sol-Gel files for $86 Million Nasdaq IPO

31.08.17|Dror Reich

The clinical-stage drug developer will remain a "controlled company" under current shareholder Arkin Dermatology

Anti-Acne Drug Developer Plans Nasdaq IPO

15.08.17|Golan Hazani

Sol-Gel approached potential underwriters. It aims to go public before the end of the year